adamantane has been researched along with endomorphin 2 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bivalacqua, TJ; Champion, HC; Kadowitz, PJ; Kastin, AJ; Zadina, JE | 1 |
Barna, I; Király, K; Kozsurek, M; Lambeir, AM; Luyten, W; Puskár, Z; Rónai, AZ; Szalai, J; Szentirmay, A | 1 |
Chang, XM; Fang, Q; Han, ZL; Li, N; Li, XH; Pan, JX; Tang, HH; Wang, P; Wang, R; Wang, ZL; Zheng, T | 1 |
3 other study(ies) available for adamantane and endomorphin 2
Article | Year |
---|---|
Vasodilator responses to the endomorphin peptides, but not nociceptin/OFQ, are mediated by nitric oxide release.
Topics: Adamantane; Analgesics, Opioid; Animals; Diuretics; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Hindlimb; Meclofenamic Acid; Morpholines; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nociceptin; Oligopeptides; Opioid Peptides; Rats; Rats, Sprague-Dawley; Vasodilation; Vasodilator Agents | 1999 |
The dipeptidyl peptidase IV (CD26, EC 3.4.14.5) inhibitor vildagliptin is a potent antihyperalgesic in rats by promoting endomorphin-2 generation in the spinal cord.
Topics: Adamantane; Animals; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Dose-Response Relationship, Drug; Hyperalgesia; Injections, Spinal; Injections, Subcutaneous; Male; Nitriles; Oligopeptides; Pyrrolidines; Rats; Rats, Wistar; Reproducibility of Results; Spinal Cord; Time Factors; Vildagliptin | 2011 |
Opposite effects of neuropeptide FF on central antinociception induced by endomorphin-1 and endomorphin-2 in mice.
Topics: Adamantane; Animals; Benzeneacetamides; Dipeptides; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Injections, Intraventricular; Male; Mice; Naltrexone; Nociception; Oligopeptides; Pyrrolidines | 2014 |